Protecting the tuberculosis drug pipeline: stating the case for the rational use of fluoroquinolones

Protecting the tuberculosis drug pipeline: stating the case for the rational use of fluoroquinolones

The use of fluoroquinolones (FQs) to treat lower respiratory tract infections (LTRI) other than tuberculosis (TB) allows selection of FQ-resistant TB when TB is misdiagnosed. This study maps national guidelines on the use of FQs for LRTI in Europe and determines the risk of FQ-resistant TB upon FQ t...

Full description

Bibliographic Details
Main Authors: Migliori, Giovanni Battista, Langendam, Miranda W., D'Ambrosio, Lia, Centis, Rosella, Blasi, Francesco, Huitric, Emma, Manissero, Davide, van der Werf, Marieke J.
Format: Online
Language:English
Published: European Respiratory Society 2012
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3461345/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3461345/

Similar Items